lycorine has been researched along with Adenocarcinoma Of Kidney in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, M; Huang, P; Li, X; Liu, C; Matsuura, E; Nasu, Y; Sadahira, T; Sun, P; Wada, K; Wang, C; Watanabe, M; Xu, A; Xu, N; Xu, P; Xu, Y; Zheng, J | 1 |
| Huang, P; Huang, YQ; Jin, Z; Li, XZ; Liu, CX; Wang, CS; Xu, K; Zhang, YM | 1 |
2 other study(ies) available for lycorine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.
Topics: Amaryllidaceae Alkaloids; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Combined Modality Therapy; CTLA-4 Antigen; Drug Synergism; Female; Growth Inhibitors; Humans; Immunologic Factors; Immunotherapy; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Phenanthridines; Plant Extracts; T-Lymphocyte Subsets; Treatment Outcome | 2017 |
[Antitumor activity of lycorine in renal cell carcinoma ACHN cell line and its mechanism].
Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Renal Cell; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Humans; Inhibitor of Apoptosis Proteins; Phenanthridines; Proto-Oncogene Proteins c-bcl-2; Survivin | 2016 |